Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Paravalvular regurgitation after conventional aortic and mitral valve replacement: A benchmark for alternative approaches Brett F. Duncan, MD, Patrick.

Where does atrial fibrillation surgery fail

A contemporary analysis of pulmonary hypertension in patients undergoing mitral valve surgery: Is this a risk factor? Daniel H. Enter, MD, Anthony Zaki,

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial Niv Ad, MD, Sari D. Holmes,

Improving health care by embracing Systems Theory

Early readmission for congestive heart failure predicts late mortality after cardiac surgery Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei,

Practice improves performance on a coronary anastomosis simulator, attending surgeon supervision does not Daniel H. Enter, MD, Xiaoying Lou, BS, Dawn.

Ground glass opacity of the lung: The veil that needs lifting

Right internal thoracic artery or saphenous vein grafting

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

Intrinsic cardiac stem cells are essential for regeneration

Scan, plan, print, practice, perform: A disruptive technology?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

How should we treat air leaks?

The use of vancomycin paste to reduce sternal wound infections after cardiac surgery— why is this still a “sticky” subject Harold L. Lazar, MD The Journal.

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian.

The lord of the rings Antonio Miceli, MD, PhD

Gastric conduit revision after esophagectomy: The raising of Lazarus

Valve replacement surgery for older individuals with preoperative atrial fibrillation: The effect of prosthetic valve choice and surgical ablation Ho.

Effect of aortic aneurysm replacement on outcomes after bicuspid aortic valve surgery: Validation of contemporary guidelines Daniel Rinewalt, MD, Patrick.

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Innovation and science: The future of valve design

Sukit Christopher Malaisrie, MD, Brett F. Duncan, MD, Chris K

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

A first start for lung transplantation?

The Cox maze IV procedure: Predictors of late recurrence

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

Instrumental variable methods in clinical research

Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor Verdi J. DiSesa, MD, MBA The Journal of.

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

A randomized, prospective pilot comparison of 3 atrial appendage elimination techniques: Internal ligation, stapled excision, and surgical excision Richard.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Functional tricuspid pathology: To treat or not to treat

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Gender differences in outcomes after surgical ablation of atrial fibrillation Sonia V. Shah, BS, Jane Kruse, BSN, Adin-Cristian Andrei, PhD, Zhi Li, MS,

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Hope should not spring eternal

The continuing challenge of congenital heart disease in China

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Toward a more rational approach in treating type B aortic dissection

Managing conflicts of interest

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

More than vital: Who bears the burden?

Out of sight, out of mind Dawn S. Hui, MD, Richard Lee, MD, MBA

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

Preoperative PFTs: The answer is blowing in the wind

Niv Ad, MD The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Journal changes and initiatives

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Deciding how much to pay for effective care

Presentation transcript:

Should paroxysmal atrial fibrillation be treated during cardiac surgery? Patrick M. McCarthy, MD, Adarsh Manjunath, BA, Jane Kruse, RN, BSN, Adin-Cristian Andrei, PhD, Zhi Li, MS, Edwin C. McGee, MD, S. Chris Malaisrie, MD, Richard Lee, MD, MBA The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 4, Pages 810-823 (October 2013) DOI: 10.1016/j.jtcvs.2013.05.015 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Summary of survivorship in the (A) original and (B-D) propensity score (PS)–matched groups. PAF, Paroxysmal atrial fibrillation; AF, atrial fibrillation; HR, hazard ratio; CI, confidence interval. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 810-823DOI: (10.1016/j.jtcvs.2013.05.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Summary of freedom from atrial fibrillation (AF) without antiarrhythmic drugs (AADs) at the last follow-up visit in the (A) original and (B-D) propensity score (PS)–matched groups. PAF, Paroxysmal atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 810-823DOI: (10.1016/j.jtcvs.2013.05.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Summary of survivorship since surgery (1A-1C) and the last follow-up (2A-2C) by study group by atrial fibrillation (AF) status at the last follow-up visit. PAF, Paroxysmal atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 810-823DOI: (10.1016/j.jtcvs.2013.05.015) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions